Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  New Frontier Health Corporation    NFH   KYG6461G1064

NEW FRONTIER HEALTH CORPORATION

(NFH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

New Frontier Health : Healthcare to Announce Second Quarter of 2020 Financial Results on August 27, 2020

08/20/2020 | 08:34am EST

New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (UFH), today announced that it plans to release its financial results for the second quarter ended June 30, 2020, before the U.S. market open on Thursday, August 27, 2020.

The Company will hold a conference call on Thursday, August 27, 2020, at 8:00 am Eastern Time (Thursday, August 27, 2020, at 8:00 pm Beijing Time) to discuss the financial results. Participants may access the call by dialing the following numbers:

United States: 1-877-407-0789
International: 1-201-689-8562
China Domestic: 86 400 120 2840
Hong Kong: 800 965 561
Conference ID: 13708749

Participants are encouraged to dial into the call at least 15 minutes in advance due to high call volume.

The replay will be accessible through September 3, 2020, by dialing the following numbers:

United States: 1-844-512-2921
International: 1-412-317-6671
Replay PIN: 13708749

A webcast will be available on the Company’s investor relations website at www.nfh.com.cn and will be archived on the site shortly after the call has concluded. A presentation to accompany the call will also be available for download on the website.

About New Frontier Health Corporation

New Frontier Health Corporation (NYSE: NFH) is the operator of United Family Healthcare (UFH), a leading private healthcare provider offering comprehensive premium healthcare services in China through a network of private hospitals and affiliated ambulatory clinics. UFH currently has nine hospitals and in total in operation or under construction in all four 1st tier cities and selected 2nd tier cities. Additional information may be found at www.nfh.com.cn.

Source: New Frontier Health Corporation


© Business Wire 2020
All news about NEW FRONTIER HEALTH CORPORATION
08:32aNEW FRONTIER HEALTH CORPORATION : to Announce Third Quarter of 2020 Financial Re..
BU
08/27NEW FRONTIER HEALTH : Announces Second Quarter 2020 Financial Results
BU
08/20NEW FRONTIER HEALTH : Healthcare to Announce Second Quarter of 2020 Financial Re..
BU
08/03NEW FRONTIER HEALTH : Announces Executive Management Team Changes
BU
07/07NEW FRONTIER HEALTH : Healthcare's United Family Healthcare Tops Ding Xiang Yuan..
BU
05/27NEW FRONTIER HEALTH : Announces First Quarter 2020 Financial Results
BU
05/22NEW FRONTIER HEALTH : Healthcare Announces Appointment of Lawrence Chia to Board..
BU
05/20NEW FRONTIER HEALTH : Healthcare to Announce First Quarter of 2020 Financial Res..
BU
05/18NEW FRONTIER HEALTH : to Participate in UBS Virtual Global Healthcare Conference..
BU
03/26NEW FRONTIER HEALTH CORPORATION : Announces Fourth Quarter and Fiscal 2019 Finan..
BU
More news
Financials
Sales 2019 2 500 M 380 M 380 M
Net income 2019 - - -
Net Debt 2019 - - -
P/E ratio 2019 -11,1x
Yield 2019 -
Capitalization 7 509 M 1 144 M 1 141 M
Capi. / Sales 2019 3,00x
Capi. / Sales 2020 3,07x
Nbr of Employees -
Free-Float 81,2%
Chart NEW FRONTIER HEALTH CORPORATION
Duration : Period :
New Frontier Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEW FRONTIER HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 84,41 CNY
Last Close Price 57,16 CNY
Spread / Highest target 71,2%
Spread / Average Target 47,7%
Spread / Lowest Target 24,1%
EPS Revisions
Managers
NameTitle
Roberta Lipson Chief Executive Officer & Director
Carl Wu President & Director
Kam Chung Leung Co-Chairman
Qi Yu Chen Co-Chairman
David Zeng Chief Operating Officer & Executive Director
Sector and Competitors